The biotech industry is one of the biggest sectors globally. The year 2015 has been quite challenging for the sector - in the first half, it continued what has been a multi-year rally and at the same time, there had been concerns about a bubble in the biotech sector, according to Seeking Alpha.
“The iShares NASDAQ Biotechnology Index ETF saw a sharp pullback in mid-July. The sell-off continued until the end of August, with IBB dropping from around $400 to just under $325”, Seeking Alpha reported.
